Anterolateral minithoracotomy versus median sternotomy for mitral valve disease: a meta-analysis
| ||||||||||||||
Chao Ding, Da-ming Jiang, Kai-yu Tao, Qun-jun Duan, Jie Li, Min-jian Kong, Zhong-hua Shen, Ai-qiang Dong. Anterolateral minithoracotomy versus median sternotomy for mitral valve disease: a meta-analysis[J]. Journal of Zhejiang University Science B, 2014, 15(6): 522-532.
@article{title="Anterolateral minithoracotomy versus median sternotomy for mitral valve disease: a meta-analysis",
author="Chao Ding, Da-ming Jiang, Kai-yu Tao, Qun-jun Duan, Jie Li, Min-jian Kong, Zhong-hua Shen, Ai-qiang Dong",
journal="Journal of Zhejiang University Science B",
volume="15",
number="6",
pages="522-532",
year="2014",
publisher="Zhejiang University Press & Springer",
doi="10.1631/jzus.B1300210"
}
%0 Journal Article
%T Anterolateral minithoracotomy versus median sternotomy for mitral valve disease: a meta-analysis
%A Chao Ding
%A Da-ming Jiang
%A Kai-yu Tao
%A Qun-jun Duan
%A Jie Li
%A Min-jian Kong
%A Zhong-hua Shen
%A Ai-qiang Dong
%J Journal of Zhejiang University SCIENCE B
%V 15
%N 6
%P 522-532
%@ 1673-1581
%D 2014
%I Zhejiang University Press & Springer
%DOI 10.1631/jzus.B1300210
TY - JOUR
T1 - Anterolateral minithoracotomy versus median sternotomy for mitral valve disease: a meta-analysis
A1 - Chao Ding
A1 - Da-ming Jiang
A1 - Kai-yu Tao
A1 - Qun-jun Duan
A1 - Jie Li
A1 - Min-jian Kong
A1 - Zhong-hua Shen
A1 - Ai-qiang Dong
J0 - Journal of Zhejiang University Science B
VL - 15
IS - 6
SP - 522
EP - 532
%@ 1673-1581
Y1 - 2014
PB - Zhejiang University Press & Springer
ER -
DOI - 10.1631/jzus.B1300210
Abstract: Objective: mitral valve disease tends to be treated with anterolateral minithoracotomy (ALMT) rather than median sternotomy (MS), as ALMT uses progressively smaller incisions to promote better cosmetic outcomes. This meta-analysis quantifies the effects of ALMT on surgical parameters and post-operative outcomes compared with MS. Methods: One randomized controlled study and four case-control studies, published in English from January 1996 to January 2013, were identified and evaluated. Results: ALMT showed a significantly longer cardiopulmonary bypass time (P=0.001) and aortic cross-clamp time (P=0.05) compared with MS. However, the benefits of ALMT were evident as demonstrated by a shorter length of hospital stay (P<0.00001). According to operative complications, the onset of new arrhythmias following ALMT decreased significantly as compared with MS (P=0.05); however, the incidence of peri-operative mortality (P=0.62), re-operation for bleeding (P=0.37), neurologic events (P=0.77), myocardial infarction (P=0.84), gastrointestinal complications (P=0.89), and renal insufficiency (P=0.67) were similar to these of MS. Long-term follow-up data were also examined, and revealed equivalent survival and freedom from mitral valve events. Conclusions: Current clinical data suggest that ALMT is a safe and effective alternative to the conventional approach and is associated with better short-term outcomes and a trend towards longer survival.
Full Text:
<5496>
CLC number: R654.2
On-line Access: 2024-08-27
Received: 2023-10-17
Revision Accepted: 2024-05-08
Crosschecked: 2014-05-26
Cited: 5
Clicked: 9138
Open peer comments: Debate/Discuss/Question/Opinion
<1>